Tanox was a biopharmaceutical company based in Houston, Texas. The company was founded by two biomedical research scientists, Nancy T. Chang and Tse Wen Chang in March 1986 with $250,000, which was a large part of their family savings at that time.

Tanox price today is $ 0.0₅1001 with a 24-hour trading volume of $ 16.43, market cap of $ 80,043, and market dominance of 0.00%. The LTX price increased 1.91% in the last 24 hours.

Talizumab (TNX-901) is a humanized monoclonal antibody that was under development by Tanox in Houston, Texas as a new-concept therapeutic for allergic diseases.

Nov 9, 2006 · Tanox's lead investigational therapy, TNX-355, is a viral-entry inhibitor antibody to treat HIV/AIDS. TNX-355 has shown significant antiviral activity in Phase 2 clinical testing.

Jan 16, 2007 · Tanox’s lead investigational therapy, TNX-355, is a viral-entry inhibitor antibody to treat HIV/AIDS. TNX-355 has shown significant antiviral activity in Phase 2 clinical testing. Tanox’s first-approved drug, Xolair (R) (omalizumab), is the first antibody approved to treat moderate-to-severe confirmed, allergic asthma.

Thanox是一个Android系统管理工具，在系统隐私和系统优化方便提供了便利的功能。 包含应用的权限管理，后台启动管理，后台运行管理，以及强大的情景模式和独特新奇的移花接木功能。

We strive to set new standards in anonymity, efficiency, and customer satisfaction, making transactions smoother and more reliable for both creators and consumers. Experience the difference with our cutting-edge solutions. 👮Tanox LTX Successfully Passes Audit Verificati...

Tanox, Inc. is a a biotechnology company, engages in the discovery and development of therapeutic monoclonal antibodies.